Spruce Biosciences, Inc. announced it raised $44 Million in an initial filing from an offering of $88 Million
Feb 28, 2020•over 5 years ago
Amount Raised
$44 Million
South San FranciscoBiotechnology
Company Information
Company
Spruce Biosciences
Location
611 Gateway Boulevard, Suite 740
South San Francisco, California, United States
About
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company aims to address significant unmet medical needs through innovative treatment solutions. Spruce has a particular focus on rare diseases and is committed to serving patient communities. They are known for their work in enzyme replacement therapies.
Related People
Funding Insights
Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
South San Francisco